PATRONO, CARLO
PATRONO, CARLO
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes
2021 Volpe, Massimo; Patrono, Carlo
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19
2021 Volpe, M.; Patrono, C.
A SPRINT towards tighter control of blood pressure in hypertension
2021 Volpe, M.; Patrono, C.
Aldosterone receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problems
2021 Patrono, Carlo; Volpe, Massimo
Decline in blood pressure control trends in the US: a real step back: comment on National Health and Nutrition Examination Survey (NHANES) data
2020 Volpe, M.; Patrono, C.
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo - Evidence derived from the study of peripheral arterial disease
1997 Davi', Giuseppe; P., Gresele; Violi, Francesco; Basili, Stefania; M., Catalano; C., Giammaresi; R., Volpato; G. G., Nenci; G., Ciabattoni; Patrono, Carlo
Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritis
2022 Galiuto, Leonarda; Patrono, Carlo
Do VERTIS-CV trial results question a class-effect of cardiovascular protection with sodium-glucose cotransporter 2 inhibitors?
2020 Volpe, M.; Patrono, C.
Efficacy of a Mediterranean diet for the secondary prevention of cardiovascular disease
2022 Galiuto, Leonarda; Patrono, Carlo
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus - Role of interleukin-6 and disease duration
2003 G., Davi'; F., Chiarelli; F., Santilli; M., Pomilio; S., Vigneri; A., Falco; Basili, Stefania; G., Ciabattoni; Patrono, Carlo
Fourth universal definition of myocardial infarction (2018)
2019 Thygesen, K.; Alpert, J. S.; Jaffe, A. S.; Chaitman, B. R.; Bax, J. J.; Morrow, D. A.; White, H. D.; Mickley, H.; Crea, F.; Van De Werf, F.; Bucciarelli-Ducci, C.; Katus, H. A.; Pinto, F. J.; Antman, E. M.; Hamm, C. W.; De Caterina, R.; Januzzi, J. L.; Apple, F. S.; Garcia, M. A. A.; Underwood, S. R.; Canty, J. M.; Lyon, A. R.; Devereaux, P. J.; Zamorano, J. L.; Lindahl, B.; Weintraub, W. S.; Newby, L. K.; Virmani, R.; Vranckx, P.; Cutlip, D.; Gibbons, R. J.; Smith, S. C.; Atar, D.; Luepker, R. V.; Robertson, R. M.; Bonow, R. O.; Steg, P. G.; O'Gara, P. T.; Fox, K. A. A.; Hasdai, D.; Aboyans, V.; Achenbach, S.; Agewall, S.; Alexander, T.; Avezum, A.; Barbato, E.; Bassand, J. -P.; Bates, E.; Bittl, J. A.; Breithardt, G.; Bueno, H.; Bugiardini, R.; Cohen, M. G.; Dangas, G.; De Lemos, J. A.; Delgado, V.; Filippatos, G.; Fry, E.; Granger, C. B.; Halvorsen, S.; Hlatky, M. A.; Ibanez, B.; James, S.; Kastrati, A.; Leclercq, C.; Mahaffey, K. W.; Mehta, L.; Muller, C.; Patrono, C.; Piepoli, M. F.; Pineiro, D.; Roffi, M.; Rubboli, A.; Sharma, S.; Simpson, I. A.; Tendera, M.; Valgimigli, M.; Van Der Wal, A. C.; Windecker, S.
Inhibition of human platelet aggregation by stable analogs of prostacyclin
1977 Togna, Giuseppina Ines; C., Gandolfi; A., Andreoni; A., Fumagalli; C., Passarotti; F., Faustini; Patrono, Carlo
Insulin resistance as a determinant of platelet activation in obese women
2006 Basili, Stefania; Giovanni, Pacini; Maria Teresa, Guagnano; Maria Rosaria, Manigrasso; Francesca, Santilli; Caterina, Pettinella; Giovanni, Ciabattoni; Patrono, Carlo; Giovanni, Davi
Iron heart
2021 Volpe, M.; Patrono, C.
Knowledge about health effects of cigarette smoking and quitting among university students: the importance of teaching nicotine dependence and treatment in the medical curriculum
2013 Grassi, Maria Caterina; Baraldo, M; Chiamulera, C; Culasso, Franco; Ferketich, AMY KATHLEEN; Raupach, T; Patrono, Carlo; Nencini, Paolo
Out-of-hospital cardiac arrest: handle with care-comment on the resuscitation outcomes consortium cardiac epidemiologic registry
2020 Volpe, M.; Patrono, C.
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism
2012 A., Dragani; A., Falco; F., Santilli; Basili, Stefania; G., Rolandi; L., Cerasa; S., Lattanzio; G., Ciabattoni; Patrono, Carlo; G., Davi
PCSK9 inhibition: not just LDL-cholesterol knock down: a glimmer for cancer
2021 Patrono, C.; Volpe, M.
Platelet activation in obese women: Role of inflammation and oxidant stress
2002 Giovanni, Davi; Maria Teresa, Guagnano; Giovanni, Ciabattoni; Basili, Stefania; Angela, Falco; Marina, Marinopiccoli; Michele, Nutini; Sergio, Sensi; Patrono, Carlo
The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk
2021 Volpe, M.; Patrono, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes | 2021 | Volpe, Massimo; Patrono, Carlo | |
| A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19 | 2021 | Volpe, M.; Patrono, C. | |
| A SPRINT towards tighter control of blood pressure in hypertension | 2021 | Volpe, M.; Patrono, C. | |
| Aldosterone receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problems | 2021 | Patrono, Carlo; Volpe, Massimo | |
| Decline in blood pressure control trends in the US: a real step back: comment on National Health and Nutrition Examination Survey (NHANES) data | 2020 | Volpe, M.; Patrono, C. | |
| Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo - Evidence derived from the study of peripheral arterial disease | 1997 | Davi', Giuseppe; P., Gresele; Violi, Francesco; Basili, Stefania; M., Catalano; C., Giammaresi; R., Volpato; G. G., Nenci; G., Ciabattoni; Patrono, Carlo | |
| Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritis | 2022 | Galiuto, Leonarda; Patrono, Carlo | |
| Do VERTIS-CV trial results question a class-effect of cardiovascular protection with sodium-glucose cotransporter 2 inhibitors? | 2020 | Volpe, M.; Patrono, C. | |
| Efficacy of a Mediterranean diet for the secondary prevention of cardiovascular disease | 2022 | Galiuto, Leonarda; Patrono, Carlo | |
| Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus - Role of interleukin-6 and disease duration | 2003 | G., Davi'; F., Chiarelli; F., Santilli; M., Pomilio; S., Vigneri; A., Falco; Basili, Stefania; G., Ciabattoni; Patrono, Carlo | |
| Fourth universal definition of myocardial infarction (2018) | 2019 | Thygesen, K.; Alpert, J. S.; Jaffe, A. S.; Chaitman, B. R.; Bax, J. J.; Morrow, D. A.; White, H. D.; Mickley, H.; Crea, F.; Van De Werf, F.; Bucciarelli-Ducci, C.; Katus, H. A.; Pinto, F. J.; Antman, E. M.; Hamm, C. W.; De Caterina, R.; Januzzi, J. L.; Apple, F. S.; Garcia, M. A. A.; Underwood, S. R.; Canty, J. M.; Lyon, A. R.; Devereaux, P. J.; Zamorano, J. L.; Lindahl, B.; Weintraub, W. S.; Newby, L. K.; Virmani, R.; Vranckx, P.; Cutlip, D.; Gibbons, R. J.; Smith, S. C.; Atar, D.; Luepker, R. V.; Robertson, R. M.; Bonow, R. O.; Steg, P. G.; O'Gara, P. T.; Fox, K. A. A.; Hasdai, D.; Aboyans, V.; Achenbach, S.; Agewall, S.; Alexander, T.; Avezum, A.; Barbato, E.; Bassand, J. -P.; Bates, E.; Bittl, J. A.; Breithardt, G.; Bueno, H.; Bugiardini, R.; Cohen, M. G.; Dangas, G.; De Lemos, J. A.; Delgado, V.; Filippatos, G.; Fry, E.; Granger, C. B.; Halvorsen, S.; Hlatky, M. A.; Ibanez, B.; James, S.; Kastrati, A.; Leclercq, C.; Mahaffey, K. W.; Mehta, L.; Muller, C.; Patrono, C.; Piepoli, M. F.; Pineiro, D.; Roffi, M.; Rubboli, A.; Sharma, S.; Simpson, I. A.; Tendera, M.; Valgimigli, M.; Van Der Wal, A. C.; Windecker, S. | |
| Inhibition of human platelet aggregation by stable analogs of prostacyclin | 1977 | Togna, Giuseppina Ines; C., Gandolfi; A., Andreoni; A., Fumagalli; C., Passarotti; F., Faustini; Patrono, Carlo | |
| Insulin resistance as a determinant of platelet activation in obese women | 2006 | Basili, Stefania; Giovanni, Pacini; Maria Teresa, Guagnano; Maria Rosaria, Manigrasso; Francesca, Santilli; Caterina, Pettinella; Giovanni, Ciabattoni; Patrono, Carlo; Giovanni, Davi | |
| Iron heart | 2021 | Volpe, M.; Patrono, C. | |
| Knowledge about health effects of cigarette smoking and quitting among university students: the importance of teaching nicotine dependence and treatment in the medical curriculum | 2013 | Grassi, Maria Caterina; Baraldo, M; Chiamulera, C; Culasso, Franco; Ferketich, AMY KATHLEEN; Raupach, T; Patrono, Carlo; Nencini, Paolo | |
| Out-of-hospital cardiac arrest: handle with care-comment on the resuscitation outcomes consortium cardiac epidemiologic registry | 2020 | Volpe, M.; Patrono, C. | |
| Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism | 2012 | A., Dragani; A., Falco; F., Santilli; Basili, Stefania; G., Rolandi; L., Cerasa; S., Lattanzio; G., Ciabattoni; Patrono, Carlo; G., Davi | |
| PCSK9 inhibition: not just LDL-cholesterol knock down: a glimmer for cancer | 2021 | Patrono, C.; Volpe, M. | |
| Platelet activation in obese women: Role of inflammation and oxidant stress | 2002 | Giovanni, Davi; Maria Teresa, Guagnano; Giovanni, Ciabattoni; Basili, Stefania; Angela, Falco; Marina, Marinopiccoli; Michele, Nutini; Sergio, Sensi; Patrono, Carlo | |
| The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk | 2021 | Volpe, M.; Patrono, C. |